Lecture 39 - Neoplasia V

  • November 2019
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Lecture 39 - Neoplasia V as PDF for free.

More details

  • Words: 792
  • Pages: 17
Neoplasia By Prof. J.T. Anim Department of Pathology

Lecture V

Topics  

Effect of neoplasm on host Effect of host on neoplasm  

Tumour immunity Spontaneous regression of malignant tumours

Effect of Neoplasm on Host 

Local effects    



Mechanical pressure Destruction of tissue (pressure/aggressive invasion) Haemorrhage +/- ulceration Infection

Systemic effects  



Fever - TNFα, IL-1 (tumour cells, macrophages) Cachexia (anorexia, malabsorption, anaerobic metabolism of neoplasm, cytokines eg. TNFα = cachexin, IL-6) Effect on immune system (immunosuppression due to tumour itself or treatment; autoimmunity – non-organ specific)

Effect of Neoplasm on Host 

Systemic effects Contd. 

Haematological effects 





Anaemia – iron deficiency, nutritional, excess Rbc destruction (AIHA)(HD, lymphomas, thymoma), MAHA (ca stomach, pancreas, colon, lung, breast), decreased erythropoietin, sideroblastic, red cell aplasia (thymoma) Increased red cell production – ectopic EPO (renal cell carcinoma, cerebellar haemangioblastoma, uterine fibroleiomyoma, liver carcinoma, ovarian carcinoma, lung carcinoma) Effects on platelets and clotting – thrombocytopaenia (immune-mediated destruction); intravascular coagulation (prostate, bronchus, stomach, breast), migratory thrombophlebitis (carcinoma of bronchus, pancreas, stomach, female genitalia, breast – mucin producing tumours)

Effect of Neoplasm on Host 

Systemic effects contd 

Cutaneous manifestations         

Acanthosis nigricans – 75% adenocarcinoma Dermatomyositis – 15% malignancy Exfoliative dermatitis – lymphomas & leukaemias Erythema gyratum repens – carcinoma of bronchus Pigmentation – carcinomatosis Pruritis – lymphomas & some carcinomas Herpes zoster – Hodgkin’s and other lymphomas Acquired ichthyosis – lymphomas Necrolytic migratory erythema - glucagonoma

Effect of Neoplasm on Host 

Neuromuscular effects  



Myopathy – carcinomas & lymphomas Myasthenic syndrome – oat cell carcinoma of bronchus, thymoma Mixed neuropathy (sensory and motor) 

     

Ca bronchus, stomach, breast, lymphoma, myeloma

Sensory neuropathy – carcinoma of bronchus Autonomic neuropathy Dementia or psychosis Cerebellar degeneration – ca bronchus, ovary, lymphoma Brain stem degeneration PMLE (papova virus) – rarely, lymphoma

Effect of Neoplasm on Host 

Systemic effects contd 

Endocrine effects  



Appropriate hormone production Ectopic/inappropriate hormone production

Non-metastatic osseous and soft tissue changes (clubbing)

Effect of Neoplasm on Host 

Inappropriate hormone production by tumour cells 

Cushing’s syndrome (ACTH production)    



Hyponatremia (ADH-like substance) 



Oat cell carcinoma of bronchus Thymoma Carcinoid tumours Medullary carcinoma of thyroid Oat cell carcinoma of bronchus

Hypoglycaemia (insulin-like substance)   

Mesothelioma Liver cell carcinoma Adrenal cortical carcinoma

Effect of Neoplasm on Host 

Inappropriate hormone production by tumour cells 

Hypercalcaemia (prostaglandins, parathormone)    



Polycythaemia (haemopoietin production)     



Squamous cell carcinoma of bronchus, cervix Renal cell carcinoma Lymphomas Breast carcinoma Renal carcionma Uterine leiomyoma Liver carcinoma Cerebellar haemangioblastoma Nephroblastoma (Wilm’s tumour)

Carcinoid syndrome (5 H-T)  

Oat cell carcinoma of bronchus Medullary carcinoma of thyroid

Effect of Neoplasm on Host 

Inappropriate hormone production by tumour cells 

Gynaecomastia (HCG or human placental lactogen)   



Hypertension (excess renin production) 



Nephroblastoma

Hyperthyroidism (TSH-like substance)   



Anaplastic/squamous cell carcinoma of bronchus Testicular tumours Hepatocellular carcinoma

Hydatidiform mole, choriocarcinoma Orchioblastoma Malignant teratoma of testis

Pigmentation (melanin stimulating hormone - MSH) 

Oat cell carcinoma of bronchus

Effect of Host on Neoplasm  



Mainly through interaction with host immune system Tumour regression – neuroblastoma, malignant melanoma, regression of metastases after removal of primary Evidence of immunological reaction 



Histology – infiltration by lymphocytes, plasma cells, macrophages (correlation with prognosis), granulomas in draining lymph nodes Immune deficiency states and malignancy – Ataxia telangiectasia, Wiskott-Aldrich, Chediak-Higashi and Iatrogenic immunosuppression – lymphomas. ?Provides indirect evidence for cancer immunosurveillance.

Effect of Host on Neoplasm 

Evidence of immunological reaction contd. 



Rejection of tumour by animal hosts (animal models show CMI controls tumour growth) Tumour associated transplantation antigens (separate from histocompatibility antigens)    

Especially irradiation and chemical-induced tumours Virally induced tumours produce TATAs – different from viral structural proteins Spontaneous tumours (animal/human) – less antigens Some neoplasms elicit CMI eg. malignant melanoma, renal carcinoma, astrocytoma

Possible mechanisms of immune tumour cytotoxicity in animal models

Spontaneous Regression 

Shrinkage of a neoplasm that may or may not lead to total disappearance.   

May be temporary May occur without therapy - spontaneous Has been observed in medical practice and in laboratory

Spontaneous Regression 

Series of 176 regressions published between 1900 and 1966 



Renal cell carcinoma, neuroblastoma, melanoma, choriocarcinoma, carcinoma of bladder In 41 cases metastases regressed after resection of primary tumour

Spontaneous Regression 

Neuroblastoma in infants – can change from malignant to benign 





Neuroblastoma - ganglioneuroma

Melanoma – regression suggests an immunological mechanism Haemangiomas – spontaneous regression

Related Documents

Lecture 39 - Neoplasia V
November 2019 9
Lecture 39
May 2020 11
Lecture 37 - Neoplasia Iii
November 2019 12
Lecture 35 - Neoplasia I
November 2019 17
Lecture 36 - Neoplasia Ii
November 2019 15
Lecture 38 - Neoplasia Iv
November 2019 11